Literature DB >> 27355449

A symptom diary to assess severe premenstrual syndrome and premenstrual dysphoric disorder.

Carolyn Janda1, Johanna N Kues1, Gerhard Andersson2,3, Maria Kleinstäuber1, Cornelia Weise1,2.   

Abstract

The differentiation between premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD) has been widely discussed. PMDD is listed as a mental disorder in the DSM-5, whereas PMS is not considered as a mental disorder in any diagnostic manual. Consequently, PMS is operationalized in different ways. Keeping a symptom diary is required to diagnose PMDD but is also recommended for PMS. The aim of our study was, therefore, to operationalize PMS and PMDD within a DSM-5-based symptom diary. We developed a symptom-intensity-score (SI-score) and an interference-score (INT-score) to evaluate the symptom diary. Ninety-eight women (aged 20-45 years) completed a symptom diary over two menstrual cycles, a retrospective screening for premenstrual symptoms, and answered additional impairment questionnaires from August 2013 to August 2015. The scores revealed moderate to good reliability (Cronbach's α = 0.83-0.96). Convergent validity was shown by significant correlations with a retrospective screening, the Pain Disability Index, and the German PMS-Impact Questionnaire. Discriminant validity was indicated by low correlations with the Big Five Inventory-10. These scores may facilitate the evaluation of prospective symptom ratings in research and clinical practice. Future research should focus on continuing to validate the scores (e.g., in an ambulatory setting).

Entities:  

Keywords:  DSM-5; menstrual cycle; premenstrual dysphoric disorder (PMDD); premenstrual syndrome (PMS); psychological diagnostics; symptom diary

Mesh:

Year:  2016        PMID: 27355449     DOI: 10.1080/03630242.2016.1206055

Source DB:  PubMed          Journal:  Women Health        ISSN: 0363-0242


  7 in total

1.  Are there temporal subtypes of premenstrual dysphoric disorder?: using group-based trajectory modeling to identify individual differences in symptom change.

Authors:  Tory A Eisenlohr-Moul; Gudrun Kaiser; Cornelia Weise; Katja M Schmalenberger; Jeff Kiesner; Beate Ditzen; Maria Kleinstäuber
Journal:  Psychol Med       Date:  2019-04-23       Impact factor: 10.592

2.  Productivity loss due to menstruation-related symptoms: a nationwide cross-sectional survey among 32 748 women.

Authors:  Mark E Schoep; Eddy M M Adang; Jacques W M Maas; Bianca De Bie; Johanna W M Aarts; Theodoor E Nieboer
Journal:  BMJ Open       Date:  2019-06-27       Impact factor: 2.692

3.  Open-label placebo treatment of women with premenstrual syndrome: study protocol of a randomised controlled trial.

Authors:  Antje Frey Nascimento; Jens Gaab; Irving Kirsch; Joe Kossowsky; Andrea Meyer; Cosima Locher
Journal:  BMJ Open       Date:  2020-02-17       Impact factor: 2.692

4.  The Physical, Psychological, and Social Day-to-Day Experience of Women Living With Endometriosis Compared to Healthy Age-Matched Controls-A Mixed-Methods Study.

Authors:  Elisabeth Olliges; Alina Bobinger; Annemarie Weber; Verena Hoffmann; Timo Schmitz; Roxana M Popovici; Karin Meissner
Journal:  Front Glob Womens Health       Date:  2021-12-15

5.  A DSM-5-based tool to monitor concurrent mood and premenstrual symptoms: the McMaster Premenstrual and Mood Symptom Scale (MAC-PMSS).

Authors:  Benicio N Frey; Olivia R Allega; Maha Eltayebani; Sabrina K Syan; Jeronimo Mendes-Ribeiro; Luciano Minuzzi
Journal:  BMC Womens Health       Date:  2022-03-30       Impact factor: 2.809

6.  The effect of a social network-based cognitive behavioral therapy intervention on the severity of premenstrual syndrome symptoms: a protocol of a randomized clinical trial study.

Authors:  Zainab Alimoradi; Somayeh Rajabalipour; Khaled Rahmani; Amir H Pakpour
Journal:  Trials       Date:  2022-04-23       Impact factor: 2.728

7.  Traditional Chinese medicine on treating premenstrual syndrome and premenstrual dysphoric disorder: A protocol for systematic review and meta-analysis.

Authors:  Mingzhou Gao; Hui Sun; Wenjun Sun; Dongmei Gao; Mingqi Qiao
Journal:  Medicine (Baltimore)       Date:  2020-10-16       Impact factor: 1.817

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.